http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
-
MEDICREA Reports 2019 Annual Results and 2020 First Quarter Sales
-
MEDICREA Is Protected From the Consequences of the COVID-19 Pandemic
-
Altius Renewable Royalties Provides Financing To Apex Clean Energy
-
MEDICREA® Announces FDA Clearance of the World’s First Patient-Matched Spinal Interbody Cages
-
MEDICREA®’s UNiD® ASI Technology Hits 5,000th Patient-Specific Spine Surgery Milestone With Strong Penetration of the Degenerative and Minimally Invasive Market Segment
-
MEDICREA® Reports 2019 Annual Sales
-
MEDICREA Announces Preliminary Discussions With U.S. Strategic Partners
-
MEDICREA® Secures 7 New US Patents Around Its Proprietary Platform Technology UNiD™ ASI And Reinforces Barriers to Entry for Competitors
-
Medicrea Reports Third Quarter 2019 Financial Results
-
MEDICREA® Hosts Third Annual User Group Meeting (MAIA) in Lyon, France Followed by Attendance at SRS in Montreal, Canada
-
Medicrea Reports First Half 2019 Financial Results
-
MEDICREA® Announces FDA Clearance of TULIP GENESIS to Complete its UNiDTM ASI platform technology
-
MEDICREA® Secures Several New Patents to Protect its Proprietary platform technology UNiD ASI
-
Medicrea Reports First Quarter 2019 Financial Results
-
Medicrea Hosts Second Annual Meeting Focused on Artificial Intelligence and Analytics in New York, USA
-
MEDICREA® Enhances Its Proprietary UNiD ASI™ Service Platform with the Addition of an FDA-Cleared Device Planning and Selection Service
-
Medicrea Reports 2018 Annual Results
-
Medicrea Reports 2018 Fourth Quarter and Annual Sales Confirmation of Strong Growth Momentum
-
Medicrea Announces $30 Million Senior Secured Notes Issue and a Warrants Issue wholly subscribed by Perceptive Advisors
-
MEDICREA® Achieves 3,000 Surgery Milestone with UNiD ASI™ and Patient Specific Implants
-
Medicrea Reports Third-Quarter Results
-
Medicrea Third Quarter 2018 Sales
-
Leading into SRS 2018, Medicrea Highlights a New Study Showing That Patients Implanted with UNiD™ Patient-Specific Rods Are 2.6 Times More Likely to Be Optimally Corrected

